Elanco Animal Health Incorporated (ELAN) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NYSE. Market cap 11.26B USD. 52-week range 19.40 to 27.98 USD. Trailing P/E 355.4. Data as of 2026-10-09.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under ...